Representative before the EPO

Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1094.87
Headquarter in Cleveland and 38 offices
active in Legal Services

Thomas Kurt Ritter has worked on the following 20 EPO patent applications which have been published in the last five years:

EP11731538

TETRAZOLONES AS INHIBITORS OF FATTY ACID SYNTHASE

IPC classification:
A61K 31/41, A61P 3/00, A61P 29/00, A61P 35/00, C07D 257/04, C07D 401/06, C07D 401/12, C07D 403/06, C07D 403/12, C07D 407/12, C07D 413/06, C07D 413/12, C07D 417/04, C07D 417/06
Agent:
Multiple attorneys, Jones Day
Status:
PATENT GRANTED
EP11726556

METHODS OF TREATING HEMATOLOGIC MALIGNANCIES USING 6-CYCLOHEXYL-1-HYDROXY-4-METHYL-2(1H)-PYRIDONE

IPC classification:
A61K 31/4418, A61P 35/02
Agent:
Multiple attorneys, Jones Day
Status:
GRANT OF PATENT INTENDED
EP11731574

HYDROXYPYRIDONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC USE FOR TREATING PROLIFERATIVE DISEASES

IPC classification:
A61K 31/4418, A61P 35/02, C07D 213/89
Agent:
Multiple attorneys, Jones Day
Status:
EXAMINATION IN PROGRESS
EP11726584

FURANYL COMPOUNDS AND THE USE THEREOF

IPC classification:
A61K 31/341, A61P 35/00, C07D 307/68
Agent:
Multiple attorneys, Jones Day
Status:
GRANT OF PATENT INTENDED
EP12700896

PHENETHYLSULFONE ISOINDOLINE DERIVATIVES AS INHIBITORS OF PDE 4 AND/OR CYTOKINES

IPC classification:
A61K 31/4035, C07D 209/48, C07H 15/26
Applicant:
Celgene Corporation
Agent:
Multiple attorneys, Jones Day
Status:
EXAMINATION IN PROGRESS
EP11755510

QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/517, A61P 29/00, A61P 35/00, A61P 37/00, C07D 401/14, C07D 403/14, C07D 405/14, C07D 413/14, C07D 417/14
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11779917

PHARMACEUTICAL FORMULATIONS OF A SUBSTITUTED DIAMINOPURINE

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/505
Applicant:
Signal Pharmaceuticals, LLC
Agent:
Multiple attorneys, Jones Day
Status:
GRANT OF PATENT INTENDED
EP12734039

PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES

IPC classification:
A61K 31/497, C07D 473/34
Applicant:
Intellikine LLC
Agent:
Multiple attorneys, Jones Day
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Julian Richard John Crump, Beresford Crump LLP
Status:
PATENT GRANTED
EP11755495

THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/4743, A61P 29/00, A61P 35/00, A61P 37/00, C07D 495/02
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755499

2-CYCLOQUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A61K 31/517, A61P 35/00, C07D 403/12, C07D 405/14
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755502

ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/517, A61P 27/06, C07D 401/14, C07D 403/12, C07D 405/14
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12175366

Tissue protective peptides and uses thereof

IPC classification:
A61K 38/00
Agent:
Multiple attorneys, Jones Day
Status:
EXAMINATION IN PROGRESS
EP11758010

AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/517, A61P 35/00, C07D 403/12
Agent:
Multiple attorneys, Jones Day
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11758009

AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/517, A61P 35/00, C07D 403/12
Agent:
Multiple attorneys, Jones Day
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11707755

ISOTOPICALLY ENRICHED ARYLSULFONAMIDE CCR3 ANTAGONISTS

IPC classification:
A61K 31/135, A61P 11/06, C07B 59/00, C07D 295/26
Agent:
Multiple attorneys, Jones Day
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755500

7-CYCLYLQUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A61K 31/517, A61P 35/02, C07D 403/12, C07D 403/14, C07D 405/14, C07D 413/14
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755501

4-AZOLYLAMINOQUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A61K 31/517, A61P 35/00, C07D 403/12, C07D 417/12
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11776943

SALTS OF ARYLSULFONAMIDE CCR3 ANTAGONISTS

IPC classification:
A61K 31/495, A61P 37/00, C07D 211/54, C07D 241/04
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755491

HYDROBROMIDE SALTS OF A PYRAZOLYLAMINOQUINAZOLINE

IPC classification:
A61K 31/517, A61P 35/00, C07D 403/12
Agent:
Multiple attorneys, Jones Day
Status:
PATENT GRANTED
EP11777005

CRYSTALINE (8S,9R)-5-FLUORO-8-(4-FLUOROPHENYL)-9-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-8,9-DIHYDRO-2H-PYRIDO[4,3,2-DE]PHTALAZIN-3(7H)-ONE TOSYLATE SALT

IPC classification:
A61K 31/5025, A61P 35/00, C07D 471/06
Agent:
Multiple attorneys, Jones Day
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature